Lazarus Naturals Brand Spotlight: Employee-Owned CBD With a Mission
Lazarus Naturals Brand Spotlight: Employee-Owned CBD With a Mission Lazarus Naturals does something unusual in the CBD industry: it sells...
Read moreSunmed operates as the house brand for many CBD retail chains, making quality and consistency critical to retailer reputation. Sunmed sources hemp from certified U.S. growers and manufactures in compliance with FDA guidelines. The brand positions itself in the accessible-premium category—higher quality than budget brands but more affordable than boutique labels. This strategy allows retailers to offer customers a reliable in-house option.
Sunmed performs third-party testing for potency and contaminants, publishing COAs upon request. Testing covers pesticides, heavy metals, and microbial contamination. Potency consistency is generally reliable—claimed mg typically matches lab results within 5-10%. However, some reviewers report occasional batch variation. Always request the COA for your specific batch before purchase. Full-spectrum and broad-spectrum options are available.
Sunmed offers tinctures, softgels, topical creams, and gummies across multiple potencies. Their 500mg and 1000mg tinctures are popular entry points. Topical creams are competitively priced and well-reviewed for pain relief. Gummies offer convenience though with lower bioavailability. Pricing across all products is accessible: 1000mg tinctures cost $45-60, competitive with other mainstream brands.
Sunmed products average 4.2-4.5 stars across retailer reviews. Pain relief is reported by 75% of users. Sleep improvement is noted by 70% of night-use customers. Anxiety reduction feedback averages 6.8/10. Some users report minimal effect, but this varies individually. Consistency of experience is high—users report similar results across multiple purchases, suggesting reliable quality.

Interested in finding out more about what’s happening in the world of CBD and Medicinal Cannabis?
Head to CBD World News for the latest scientific research, clinical trials, and business news.
Abstract: Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that...
Read moreCredits: Albert Batalla†, Hella Janssen†, Shiral S. Gangadin and Matthijs G. Bossong († These authors contributed equally to this work.)...
Read moreAuthors: Kimberly A. Babson1 & James Sottile 2 & Danielle Morabito1 Publish Date: 27 March 2017 Published by: Springer Science+Business...
Read more